As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
$500 a bottle would be practically giving it away in the US. Most life sustaining meds or the rare cure are sold at unfathomable prices. One of my post-transplant anti rejection meds is $60,000 a month
$500 a bottle would be practically giving it away in the US. Most life sustaining meds or the rare cure are sold at unfathomable prices. One of my post-transplant anti rejection meds is $60,000 a month